Skin Barrier Function in Women Using UV Nail Lamps

July 13, 2026 updated by: University of Split, School of Medicine

Comparison of Objective Skin Barrier Function Parameters Between Women Who Use and Women Who Do Not Use UV Nail Lamps for Nail Treatments

The goal of this observational study is to compare objective parameters of skin barrier function between healthy adult women who regularly use UV lamps during nail treatments and women who do not use UV lamps.

The main questions it aims to answer are:

  • Do women who regularly use UV lamps for nail treatments show differences in skin barrier function compared to women who do not use UV lamps?
  • Are transepidermal water loss, skin hydration, and erythema associated with regular exposure to UV lamps used for nail treatments?
  • Does the duration of UV lamp use influence skin barrier function parameters?

Researchers will compare women who regularly use UV lamps during nail treatments with women who have natural nails and do not regularly expose their hands to UV lamps.

Participants will:

  • Attend a single study visit.
  • Complete a short questionnaire regarding nail care habits and duration of UV lamp use.
  • Undergo non-invasive measurements of skin barrier function on the hands, including transepidermal water loss, skin hydration, and erythema assessments.

Study Overview

Status

Recruiting

Conditions

Study Type

Observational

Enrollment (Estimated)

30

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Split, Croatia, 2100
        • Recruiting
        • University of Split School of Medicine
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Healthy adult women recruited from the general population. Participants will be classified into two groups based on their self-reported use of UV nail lamps during nail treatments: regular users of UV nail lamps and women who do not regularly use UV nail lamps and have natural nails.

Description

Inclusion Criteria:

  • Healthy adult women (≥18 years of age)
  • Willing and able to provide written informed consent
  • Willing to complete the study questionnaire

Exclusion Criteria:

  • Active skin diseases (e.g., psoriasis, vitiligo, or other dermatological conditions)
  • Allergic contact dermatitis
  • Pregnancy or breastfeeding
  • Use of topical or systemic corticosteroids, immunosuppressive drugs, or antihistamines

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Regular UV Nail Lamp Users
Healthy adult women who regularly undergo nail treatments involving exposure to UV lamps.
Non-Users of UV Nail Lamps
Healthy adult women who do not regularly undergo nail treatments involving exposure to UV lamps and have natural nails.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Transepidermal Water Loss (TEWL)
Time Frame: Day 1 (single study visit)
Skin barrier function will be assessed by measuring transepidermal water loss using a Tewameter TM 300 probe. Values will be expressed in g/m²/h
Day 1 (single study visit)
Change in Skin Hydration
Time Frame: Day 1 (single study visit)
Hydration of the stratum corneum will be assessed using a Corneometer CM 825 probe.
Day 1 (single study visit)
Change in Skin Erythema
Time Frame: Day 1 (single study visit)
Skin erythema will be assessed using a Mexameter MX 18 probe.
Day 1 (single study visit)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Josipa Bukić, University of Split, School of Medicine

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2026

Primary Completion (Estimated)

July 1, 2027

Study Completion (Estimated)

July 1, 2027

Study Registration Dates

First Submitted

July 7, 2026

First Submitted That Met QC Criteria

July 7, 2026

First Posted (Actual)

July 13, 2026

Study Record Updates

Last Update Posted (Actual)

July 15, 2026

Last Update Submitted That Met QC Criteria

July 13, 2026

Last Verified

July 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe